HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cimetidine for erythropoietic protoporphyria.

AbstractBACKGROUND:
Erythropoietic protoporphyria (EPP) is caused by deficiency of the enzyme converting protoporphyrin IX (PpIX) into heme resulting in accumulation of PpIX; leading to photosensitivity and liver toxicity. Cimetidine might inhibit δ-aminolevulinic acid synthase influencing the heme biosynthesis. We present cases with EPP treated with cimetidine at our department, and a literature review.
METHODS:
Systematic searches were performed to identify literature describing EPP patients treated with cimetidine. On that ground we treated EPP patients with cimetidine through spring and summer in 2020 and 2021 at our department. Their erythrocyte PpIX level and standard blood and liver parameters were collected before and during 4 months of treatment. Using a questionnaire, patients were asked about change in photosensitivity, side effects, and whether they would like to resume treatment in the spring of 2022.
RESULTS:
Literature searches identified 9 patients treated with cimetidine. Four were outpatients reporting decreased photosensitivity. At our department 18 outpatients started treatment. Fifteen used oral cimetidine daily for 4 months or more providing a significant decrease in erythrocyte PpIX with a median of 20% (range: -18% to 53%) after 4 months. Eleven of the 15 patients reported a decrease in photosensitivity during treatment, 3 patients were unsure, and 1 patient experienced unchanged photosensitivity. Only mild side effects were reported. Fourteen patients requested to resume treatment in the spring of 2022.
CONCLUSIONS:
These cases suggest that cimetidine can lower erythrocyte PpIX in patients with EPP.
AuthorsIda M Heerfordt, Catharina M Lerche, Hans Christian Wulf
JournalPhotodiagnosis and photodynamic therapy (Photodiagnosis Photodyn Ther) Vol. 38 Pg. 102793 (Jun 2022) ISSN: 1873-1597 [Electronic] Netherlands
PMID35245673 (Publication Type: Journal Article, Review)
CopyrightCopyright © 2022. Published by Elsevier B.V.
Chemical References
  • Protoporphyrins
  • Heme
  • Cimetidine
  • Ferrochelatase
Topics
  • Cimetidine (therapeutic use)
  • Ferrochelatase
  • Heme
  • Humans
  • Photochemotherapy (methods)
  • Photosensitivity Disorders (drug therapy)
  • Protoporphyria, Erythropoietic
  • Protoporphyrins (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: